EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease

B. Leyland-Jones

European Journal of Cancer Supplements · 2004

DOI: 10.1016/j.ejcsup.2004.01.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer Supplements, 2004. Verfasst von B. Leyland-Jones. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Leyland-Jones, B. (2004). Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease. European Journal of Cancer Supplements. https://doi.org/10.1016/j.ejcsup.2004.01.003

Vancouver

Leyland-Jones B. Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease. European Journal of Cancer Supplements. 2004. doi:10.1016/j.ejcsup.2004.01.003

BibTeX
@article{LeylandJones2004,
  author = {Leyland-Jones, B.},
  title = {Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease},
  journal = {European Journal of Cancer Supplements},
  year = {2004},
  doi = {10.1016/j.ejcsup.2004.01.003}
}
Kostenlos starten →